Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AZN compared with MRSH: revenue, margins and what each company keeps, and the suppliers and customers both name
AZN
Astrazeneca PLC
Change
Mkt cap
Revenue
Revenue
MRSH
Marsh & McLennan Companies, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AZN
Astrazeneca PLC
vs
MRSH
Marsh & McLennan Companies, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AZN
20
ARQT
Arcutis Biotherapeutics
customer
GRAL
Grail
supplier
RCUS
Arcus Biosciences
customer
NKTR
Nektar Therapeutics
supplier
16 more · AZN chain
›
Shared
0
No disclosed counterparties: MRSH.
Only MRSH
0
None
Role chip = supplier or customer
Source: SEC EDGAR
AZN
Astrazeneca PLC
Change
186.20
▼
−0.35%
· post 187.60
Mkt cap
$289.1B
Revenue
—
Revenue
—
MRSH
Marsh & McLennan Companies, Inc.
Change
204.94
▼
−2.14%
· post 204.20
Closed
Nov 6 '26
Mkt cap
$97.4B
Revenue
$6.6B
Q3 FY26
Revenue
$26.1B
FY25
vs
Compare
Closed
Nov 6 '26
AZN
Astrazeneca PLC
vs
MRSH
Marsh & McLennan Companies, Inc.
186.20
▼
−0.35%
post 187.60
Price
204.94
▼
−2.14%
post 204.20
$289.1B
Mkt cap
$97.4B
—
Revenue
$6.6B
Q3 FY26
—
Revenue
$26.1B
FY25
Change
Change
AZN
186.20
▼
−0.35%
vs
MRSH
204.94
▼
−2.14%
Closed
Nov 6 '26